Covidien Faces Challenge Of Accelerating Growth After Spin-Off From Tyco
This article was originally published in The Gray Sheet
Executive Summary
Newly independent medical technology firm Covidien plans select acquisitions and divestitures as well as increased licensing activity to help accelerate growth following its June 29 spin-off from parent company Tyco International